Page last updated: 2024-08-22

n-methylaspartate and Alzheimer Disease

n-methylaspartate has been researched along with Alzheimer Disease in 107 studies

Research

Studies (107)

TimeframeStudies, this research(%)All Research%
pre-19903 (2.80)18.7374
1990's15 (14.02)18.2507
2000's39 (36.45)29.6817
2010's31 (28.97)24.3611
2020's19 (17.76)2.80

Authors

AuthorsStudies
Jeong, YI; Kim, D; Kim, T; Park, JS1
Alberdi, E; Balantzategi, U; Capetillo-Zarate, E; Luchena, C; Matute, C; Ortiz-Sanz, C; Quintela-López, T; Ruiz, A; Zuazo-Ibarra, J; Zugaza, JL1
Kusiak, A; Ossowska, A; Świetlik, D1
Lipton, SA1
Acebes, Á; Acevedo-Arozena, A; Brito-Armas, JM; Cuesto, G; Estévez-Silva, HM; Marcellino, DJ; Romero, N1
Barger, SW; Wu, S; Zhang, H; Zhou, J1
Ganeshpurkar, A; Kumar, A; Kumar, D; Sharma, A; Singh, R; Singh, SK; Swetha, R1
Alvarez-Periel, E; Chowdhury, S; Ghura, S; Jordan-Sciutto, K; Lopez Lloreda, C1
Baeta-Corral, R; De la Fuente, M; Giménez-Llort, L1
Cruz-Martins, N; Ezzat, SM; Kumar, D; Li, L; Painuli, S; Semwal, P; Sharifi-Rad, J; Taheri, Y; Zam, W; Zuo, P1
Aguinaga, D; Franco, R; Navarro, G; Raïch, I; Rivas-Santisteban, R; Saura, CA1
Chen, YY; Li, HP; Li, Q; Qu, LJ; Xue, Y; Yin, JT; Zhao, XF1
Chuang, YA; Kirkwood, A; Liu, W; Redding-Ochoa, J; Savonenko, AV; Shi, L; Worley, PF; Wu, J; Yang, L; Zhang, W1
Emwas, AH; Jaremko, M; Khalilullah, H; Kumar, M; Kumar, P; Narang, R; Singh, V; Sudhakar, K; Thakral, S; Verma, A; Yadav, A1
Bassi, MS; Buttari, F; Carta, M; Centonze, D; De Rosa, A; Di Maio, A; Errico, F; Gilio, L; Morelli, M; Nuzzo, T; Sasabe, J; Serra, M; Sulzer, D; Usiello, A1
Becker, S; Cima-Omori, MS; Honigmann, A; Savastano, A; Shen, Z; Sun, D; Varga, SJ; Zweckstetter, M1
Lewis, SJ; Seckler, JM1
Chuchmacz, J; Czarnecka, K; Szymański, P; Wójtowicz, P1
Babaei, P1
Kuhn, RJ; Sirohi, D1
Alam, MP; Bai, D; Bilousova, T; Elias, CJ; Evseenko, D; John, V; Spilman, P; Vadivel, K1
Evans, CE; Freeman, TJ; Good, MA; Hvoslef-Eide, M; Kidd, EJ; Thomas, RS1
Brummer, T; Endres, K; Fellgiebel, A; Lichtenthaler, SF; Müller, SA; Pan-Montojo, F; Tomita, T; Yoshida, F1
Arnold, DB; Bayer, KU; Cook, SG; Goodell, DJ; Restrepo, S1
Angelopoulou, E; Piperi, C1
Chen, Y; Deng, H; Dong, X; Li, K; Wang, L; Wang, X; Wu, Y; Xu, Y; Zhao, Y1
Mattson, MP; Wang, Y1
Chen, P; Chen, S; Deng, Y; Wei, J; Xiong, Z; Yan, Z1
Huang, YJ; Lane, HY; Lin, CH; Lin, CJ; Tsai, GE1
Han, SH1
Han, SH; Mook-Jung, I1
Borsello, T; Calabresi, P; Costa, C; de Iure, A; Di Filippo, M; Ghiglieri, V; Sclip, A; Tantucci, M; Tozzi, A1
Cheng, J; Gu, Z; Liu, W; Qin, L; Yan, Z; Zhong, P1
Arendt, T; Holzer, M; Stieler, J1
Arias-Carrión, O; Caixeta, L; Campos, C; Machado, S; Nardi, AE; Paes, F; Rocha, NB; Rocha, SA; Telles-Correia, D; Vieira, RT; Yuan, T1
Glick, JL; McMillan, PA1
Bermúdez-Rattoni, F; Delint-Ramírez, I; Díaz-Cintra, S; Morin, JP1
Altomare, CD; Cellamare, S; de Candia, M; Denora, N; Majellaro, M; Tricarico, D; Zaetta, G1
Amin, ND; Binukumar, BK; Grant, P; Kesavapany, S; Kuntz, S; Mishra, SK; Pant, HC; Reddy, P; Seo, J; Shukla, V; Steiner, J; Tsai, LH1
Cavaliere, A; Ciavardelli, D; di Ilio, C; Drago, D; Mascetra, N; Sensi, SL; Zatta, P1
Alpérovitch, A; Dartigues, JF; Lacombe, JM; Pasquier, F; Robert, P; Tzourio, C; Vidal, JS1
Avila, J; Goñi-Oliver, P; Hernández, F1
Bakshi, K; Frankfurt, M; Morain, P; Shen, C; Trocmé-Thibierge, C; Wang, HY1
He, Y; Sheng, W; Simonyi, A; Sun, AY; Sun, GY; Weisman, GA; Wood, WG1
Goussakov, I; Miller, MB; Stutzmann, GE1
Cutler, RG; Furukawa, K; Greig, NH; Jiang, H; Lahiri, DK; Lee, JH; Liu, D; Mattson, MP; Mughal, M; Pitta, M; Ray, B; Villarreal, J1
Becker, KG; Gleichmann, M; Kobilo, T; Markesbery, WR; Mattson, MP; Mughal, MR; Pazin, MJ; Troncoso, JC; van Praag, H; Wood, WH; Zhang, Y; Zonderman, AB1
Cao, G; Holland, EA; Lipton, SA; McKercher, SR; Nakamura, T; Qu, J1
Auberson, YP; Bajouco, LM; Ferreira, IL; Mota, SI; Oliveira, CR; Rego, AC1
Aarsland, D; Ballard, C; Bullock, R; Corbett, A; Francis, PT; Hanney, M; Johnson, T; Jones, EL; Lawrence, D; Prasher, V; Tyrer, S; Williams, N; Yu, LM1
Hrubá, E; Korábecný, J; Kuca, K; Musílek, K; Nepovímová, E; Opletalová, V; Soukup, O; Spilovská, K; Zemek, F1
Nakamura, Y1
Doody, R; Ferris, S; Möbius, HJ; Reisberg, B; Schmitt, F; Stöffler, A1
Gruol, DL; Qiu, Z1
Bleich, S; Kornhuber, J; Wiltfang, J1
Bleich, S; Kornhuber, J; Römer, K; Wiltfang, J1
Grossman, H; Samuels, SC1
De Mello, FG; Ferreira, ST; Louzada, PR; Mendonca-Silva, DL; Noël, F; Paula Lima, AC1
Daniele, A; Di Lazzaro, V; Dileone, M; Gainotti, G; Ghirlanda, S; Marra, C; Oliviero, A; Pilato, F; Saturno, E; Tonali, PA1
Berezov, T; Boldyrev, A; Carpenter, DO; Koudinov, A1
Haupt, M; Pirk, O; Stoppe, G1
Bowen, RL; Gregory, CW1
Perras, C1
Humpel, C; Moser, KV1
Schmitt, HP1
Almeida, CG; Choi, EY; Gouras, GK; Greengard, P; Lombroso, PJ; Moran, T; Nairn, AC; Nong, Y; Paul, S; Salter, MW; Snyder, EM1
Souder, E1
Artioli, P; De Ronchi, D; Quartesan, R; Serretti, A1
Cheng, XR; Du, GH; Sun, L1
Smith, DJ1
Cotter, VT1
Burnashev, N; Farkas, T; Fülöp, L; Harkany, T; Härtig, W; Holmgren, C; Min, R; Penke, B; Shemer, I; Sousa, KM; Tanila, H; Zilberter, M; Zilberter, Y1
Gu, Z; Lipton, SA; Ma, Y; Masliah, E; Nakamura, T; Nomura, Y; Shi, ZQ; Uehara, T; Yao, D1
Christensen, MD; White, HK1
Felszeghy, K; Horváth, J; Kasza, A; Kurunczi, A; Laroche, S; Párducz, A; Penke, B; Penke, Z; Sipos, E; Toldi, J1
Downey, D1
Chalimoniuk, M; Lee, JC; Shelat, PB; Simonyi, A; Strosznajder, JB; Sun, AY; Sun, GY; Wang, JH1
Choi, DW; Weiss, JH; Yin, HZ1
Fonnum, F; Myhrer, T; Oksengård, AR; Paulsen, RE; Wangen, K1
Angeretti, N; Forloni, G; Smiroldo, S1
Brunner, LC; Cotman, CW; Joyce, JN; Marshall, JF; Ułas, J; Weihmuller, FB1
Chouinard, ML; Gaitan, D; Wood, PL1
Kornhuber, J; Weller, M1
Couratier, P; Esclaire, F; Hugon, J; Lesort, M; Sindou, P; Yardin, C1
Dalmaz, C; Gutierrez-Figueroa, GP; Izquierdo, I1
Ceuterick, C; Checler, F; Cordell, B; Cras, P; De Jonghe, C; Dewachter, I; Kumar-Singh, S; Lübke, U; Moechars, D; Naidu, A; Van Broeckhoven, C; Van Leuven, F1
Beyreuther, K; Emilien, G; Maloteaux, JM; Masters, CL1
Behrens, MI; Fagan, AM; Han, BH; Holtzman, DM; Lendon, CL; Muller, MC; Salimi, K1
Brusa, R; Casarini, M; Diodato, E; Grilli, M; Lozza, G; Memo, M; Ongini, E; Rozmahel, R; St George-Hyslop, P; Uberti, D; Westaway, D1
Jeśko, H; Strosznajder, JB; Strosznajder, RP1
de Gregorio-Rocasolano, N; Paul, SM; Petegnief, V; Saura, J1
Hu, GY; Zhang, JM1
Chen, QS; Shimahara, T; Wei, WZ; Xie, CW1
Grosche, J; Harkany, T; Härtig, W; Hortobágyi, T; Luiten, PG; Mulder, J; Penke, B; Varga, C1
Bragin, V; Davis, KL; Haroutunian, V; Merril, CR; Robakis, NK; Sambamurti, K; Santucci, AC; VanderPutten, D; Wallace, WC1
Klunk, WE; McClure, RJ; Pettegrew, JW1
Cooper, JD; Sofroniew, MV; Svendsen, CN1
Fujiwara, M; Fukunaga, R; Kameyama, M; Ninomiya, H; Shimohama, S; Taniguchi, T1
Chalmers, DT; Dewar, D; Graham, DI; McCulloch, J; Shand, A1
Baskys, A; Carlen, PL; Reynolds, JN1
Cotman, CW; Koh, JY; Yang, LL1
Cotman, CW; Geddes, JW1
D'Amato, CJ; Greenamyre, JT; Penney, JB; Young, AB1
Cotman, CW; Monaghan, DT1

Reviews

25 review(s) available for n-methylaspartate and Alzheimer Disease

ArticleYear
Towards development of disease-modifying therapy for Alzheimer's disease using redox chemical biology pathways.
    Current opinion in pharmacology, 2022, Volume: 66

    Topics: Alzheimer Disease; Animals; Antioxidants; Biology; Cysteine; Kelch-Like ECH-Associated Protein 1; Mice; N-Methylaspartate; NF-E2-Related Factor 2; Oxidation-Reduction

2022
Serine Racemase Expression Differentiates Aging from Alzheimer's Brain.
    Current Alzheimer research, 2022, Volume: 19, Issue:7

    Topics: Aging; Alzheimer Disease; Brain; Humans; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Serine

2022
NMDA Inhibitors: A Potential Contrivance to Assist in Management of Alzheimer's Disease.
    Combinatorial chemistry & high throughput screening, 2023, Volume: 26, Issue:12

    Topics: Alzheimer Disease; Humans; Memantine; N-Methylaspartate; Neurodegenerative Diseases; Receptors, N-Methyl-D-Aspartate

2023
Alzheimer's disease: Molecular aspects and treatment opportunities using herbal drugs.
    Ageing research reviews, 2023, Volume: 88

    Topics: Acetylcholine; Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Humans; N-Methylaspartate

2023
Advances in D-Amino Acids in Neurological Research.
    International journal of molecular sciences, 2020, Oct-03, Volume: 21, Issue:19

    Topics: Alzheimer Disease; Amino Acids; Brain; Brain Chemistry; Humans; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Schizophrenia

2020
Memantine in neurological disorders - schizophrenia and depression.
    Journal of molecular medicine (Berlin, Germany), 2021, Volume: 99, Issue:3

    Topics: Alzheimer Disease; Antidepressive Agents; Antipsychotic Agents; Clinical Trials as Topic; Depression; Drug Repositioning; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Memantine; N-Methylaspartate; Neuronal Plasticity; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Serotonin 5-HT3 Receptor Antagonists

2021
NMDA and AMPA receptors dysregulation in Alzheimer's disease.
    European journal of pharmacology, 2021, Oct-05, Volume: 908

    Topics: Alzheimer Disease; Amyloid beta-Peptides; N-Methylaspartate; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission

2021
Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.
    Neuromolecular medicine, 2019, Volume: 21, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antigens, Neoplasm; Apoptosis; Blood-Brain Barrier; Brain-Derived Neurotrophic Factor; Drug Evaluation, Preclinical; Fingolimod Hydrochloride; Humans; Immunologic Factors; Inflammation; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinases; Models, Biological; N-Methylaspartate; Nerve Tissue Proteins; Neuroimmunomodulation; Neuroprotective Agents; Phosphotransferases (Alcohol Group Acceptor); Rats; Signal Transduction; Species Specificity; Sphingolipids; Sphingosine-1-Phosphate Receptors

2019
NMDA neurotransmission dysfunction in mild cognitive impairment and Alzheimer's disease.
    Current pharmaceutical design, 2014, Volume: 20, Issue:32

    Topics: Aged; Aging; Alzheimer Disease; Animals; Brain; Cognitive Dysfunction; Disease Models, Animal; Drug Design; Humans; N-Methylaspartate; Neuronal Plasticity; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission

2014
Diverse molecular targets for therapeutic strategies in Alzheimer's disease.
    Journal of Korean medical science, 2014, Volume: 29, Issue:7

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Antibodies, Monoclonal; Brain; Humans; Immunotherapy; N-Methylaspartate; tau Proteins

2014
Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer's disease pathology.
    Journal of neural transmission (Vienna, Austria : 1996), 2015, Volume: 122, Issue:4

    Topics: Alzheimer Disease; Animals; Brain; Hibernation; Humans; N-Methylaspartate; Neurons; Phosphorylation; Synapses; tau Proteins

2015
Treatment of Cognitive Deficits in Alzheimer's disease: A psychopharmacological review.
    Psychiatria Danubina, 2016, Volume: 28, Issue:1

    Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Humans; N-Methylaspartate

2016
Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease.
    Molecular neurobiology, 2010, Volume: 41, Issue:2-3

    Topics: Alzheimer Disease; Animals; Antioxidants; Flavonoids; Humans; Isoenzymes; Molecular Structure; N-Methylaspartate; NADPH Oxidases; Oxidation-Reduction; Oxidative Stress; Phenols; Phospholipases A2; Plant Extracts; Polyphenols; Receptors, N-Methyl-D-Aspartate; Signal Transduction

2010
[Intended pharmacotherapeutical approaches of Alzheimer's disease therapy].
    Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti, 2012, Volume: 61, Issue:1-2

    Topics: Alzheimer Disease; Cholinesterase Inhibitors; Humans; Memantine; N-Methylaspartate

2012
Glutamate and the glutamate receptor system: a target for drug action.
    International journal of geriatric psychiatry, 2003, Volume: 18, Issue:Suppl 1

    Topics: Alzheimer Disease; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; N-Methylaspartate; Neuroprotective Agents; Receptors, Glutamate; Synaptic Transmission

2003
Emerging therapeutics for Alzheimer's disease: an avenue of hope.
    CNS spectrums, 2003, Volume: 8, Issue:11

    Topics: Alzheimer Disease; Antioxidants; Brain; Cardiovascular Agents; Chelating Agents; Cholinesterase Inhibitors; Clinical Trials as Topic; Drug Therapy, Combination; Humans; N-Methylaspartate; Nootropic Agents; Vaccines

2003
Novel therapeutic strategies for Alzheimer's disease based on the forgotten reproductive hormones.
    Cellular and molecular life sciences : CMLS, 2005, Volume: 62, Issue:3

    Topics: Aging; Alzheimer Disease; Enzyme Inhibitors; Female; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Luteinizing Hormone; Male; N-Methylaspartate

2005
Neuropathology in Alzheimer's disease: target of pharmacotherapy.
    Journal of the American Academy of Nurse Practitioners, 2005, Volume: Suppl

    Topics: Acetylcholine; Alzheimer Disease; Amyloid beta-Peptides; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cholinesterase Inhibitors; Disease Progression; Estrogens; Glutamic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; N-Methylaspartate; Neurofibrillary Tangles; Neuropharmacology; Neurotransmitter Agents

2005
Genes involved in Alzheimer's disease, a survey of possible candidates.
    Journal of Alzheimer's disease : JAD, 2005, Volume: 7, Issue:4

    Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Cathepsin C; Cathepsin G; Cathepsins; DNA, Complementary; Gene Expression; Humans; Membrane Glycoproteins; Membrane Transport Proteins; N-Methylaspartate; Nerve Tissue Proteins; Neurofibrillary Tangles; Plaque, Amyloid; Serine Endopeptidases; Serotonin Plasma Membrane Transport Proteins; Synaptic Transmission; Tryptophan Hydroxylase

2005
[Advances in vulnerable mechanisms of selectively vulnerable neurons].
    Sheng li ke xue jin zhan [Progress in physiology], 2005, Volume: 36, Issue:3

    Topics: Alzheimer Disease; Animals; Brain; Brain Ischemia; Hippocampus; Humans; N-Methylaspartate; Neurons

2005
Alzheimer's disease: issues and challenges in primary care.
    The Nursing clinics of North America, 2006, Volume: 41, Issue:1

    Topics: Activities of Daily Living; Aged; Alzheimer Disease; Caregivers; Cholinesterase Inhibitors; Disease Progression; Family; Geriatric Assessment; Geriatric Nursing; Humans; Mass Screening; N-Methylaspartate; Neuropsychological Tests; Nurse's Role; Nursing Assessment; Office Visits; Patient Education as Topic; Primary Health Care; Psychiatric Status Rating Scales; Quality of Life; Self Efficacy; Severity of Illness Index; United States

2006
Dementia assessment and management.
    Journal of the American Medical Directors Association, 2007, Volume: 8, Issue:3 Suppl 2

    Topics: Activities of Daily Living; Advance Care Planning; Aged; Aged, 80 and over; Alzheimer Disease; Caregivers; Cholinesterase Inhibitors; Dementia; Dementia, Vascular; Humans; Lewy Body Disease; Long-Term Care; Medical History Taking; Middle Aged; N-Methylaspartate; Neurologic Examination; Nutrition Therapy; Physical Examination; Practice Guidelines as Topic; Safety; Social Support

2007
Pharmacologic management of Alzheimer disease.
    The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 2008, Volume: 40, Issue:1

    Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Therapy, Combination; Galantamine; Humans; Indans; Memantine; N-Methylaspartate; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine

2008
[New therapeutic possibilities with low-affinity NMDA receptor antagonists].
    Der Nervenarzt, 1996, Volume: 67, Issue:1

    Topics: Aged; Alzheimer Disease; Amantadine; Antiparkinson Agents; Excitatory Amino Acid Antagonists; Glutamine; Humans; Memantine; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Receptors, Phencyclidine

1996
Prospects for pharmacological intervention in Alzheimer disease.
    Archives of neurology, 2000, Volume: 57, Issue:4

    Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspartic Acid Endopeptidases; Cholinesterase Inhibitors; Clinical Trials as Topic; Donepezil; Endopeptidases; Hippocampus; Humans; Indans; N-Methylaspartate; Nerve Growth Factors; Nicotine; Piperidines; Tacrine

2000

Trials

2 trial(s) available for n-methylaspartate and Alzheimer Disease

ArticleYear
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial.
    Lancet (London, England), 2012, Feb-11, Volume: 379, Issue:9815

    Topics: Adult; Alzheimer Disease; Cognition; Dementia; Double-Blind Method; Down Syndrome; Female; Humans; Male; Memantine; Middle Aged; N-Methylaspartate

2012
Memantine in moderate-to-severe Alzheimer's disease.
    The New England journal of medicine, 2003, Apr-03, Volume: 348, Issue:14

    Topics: Activities of Daily Living; Aged; Alzheimer Disease; Behavior; Cognition; Disease Progression; Excitatory Amino Acid Antagonists; Female; Humans; Male; Memantine; Middle Aged; N-Methylaspartate; Severity of Illness Index

2003

Other Studies

80 other study(ies) available for n-methylaspartate and Alzheimer Disease

ArticleYear
The Effect of Oxidative Stress and Memantine-Incorporated Reactive Oxygen Species-Sensitive Nanoparticles on the Expression of
    International journal of molecular sciences, 2021, Nov-15, Volume: 22, Issue:22

    Topics: Alzheimer Disease; Animals; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Drug Liberation; Humans; Male; Memantine; Mice; Mice, Inbred BALB C; Mice, Nude; N-Methylaspartate; Nanoparticles; Nerve Tissue Proteins; Neuroblastoma; Optical Imaging; Oxidative Stress; Particle Size; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Signal Transduction

2021
Amyloid β / PKC-dependent alterations in NMDA receptor composition are detected in early stages of Alzheimer´s disease.
    Cell death & disease, 2022, 03-19, Volume: 13, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Hippocampus; Humans; Integrin beta1; Mice; N-Methylaspartate; Protein Kinase C; Receptors, N-Methyl-D-Aspartate; Synapses

2022
Computational Modeling of Therapy with the NMDA Antagonist in Neurodegenerative Disease: Information Theory in the Mechanism of Action of Memantine.
    International journal of environmental research and public health, 2022, 04-14, Volume: 19, Issue:8

    Topics: Alzheimer Disease; Computer Simulation; Humans; Information Theory; Memantine; N-Methylaspartate; Neurodegenerative Diseases; Receptors, N-Methyl-D-Aspartate

2022
Pridopidine Promotes Synaptogenesis and Reduces Spatial Memory Deficits in the Alzheimer's Disease APP/PS1 Mouse Model.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2022, Volume: 19, Issue:5

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Hydrogen Peroxide; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; N-Methylaspartate; Neurodegenerative Diseases; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats

2022
Combined ligand-based and structure-based design of PDE 9A inhibitors against Alzheimer's disease.
    Molecular diversity, 2022, Volume: 26, Issue:5

    Topics: Alzheimer Disease; Calcium; Calmodulin; Humans; Ligands; Molecular Docking Simulation; Molecular Dynamics Simulation; N-Methylaspartate; Phosphodiesterase Inhibitors

2022
HIV-Associated Insults Modulate ADAM10 and Its Regulator Sirtuin1 in an NMDA Receptor-Dependent Manner.
    Cells, 2022, 09-22, Volume: 11, Issue:19

    Topics: ADAM10 Protein; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; HIV Infections; Humans; Membrane Proteins; N-Methylaspartate; Proteasome Inhibitors; Rats; Receptors, N-Methyl-D-Aspartate; Sirtuin 1

2022
Sex-dependent worsening of NMDA-induced responses, anxiety, hypercortisolemia, and organometry of early peripheral immunoendocrine impairment in adult 3xTg-AD mice and their long-lasting ontogenic modulation by neonatal handling.
    Behavioural brain research, 2023, 02-13, Volume: 438

    Topics: Alzheimer Disease; Animals; Anxiety; Corticosterone; Disease Models, Animal; Female; Male; Mice; Mice, Transgenic; N-Methylaspartate

2023
The Expression of Cellular Prion Protein, PrPC, Favors pTau Propagation and Blocks NMDAR Signaling in Primary Cortical Neurons.
    Cells, 2023, 01-11, Volume: 12, Issue:2

    Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Humans; Mice; Mice, Transgenic; N-Methylaspartate; Neurons; Phosphorylation; Prion Proteins; Receptors, N-Methyl-D-Aspartate

2023
N-methyl-D-aspartic acid receptor 2A functionalized stationary phase: A reliable method for pursuing potential ligands against Alzheimer's disease from natural products.
    CNS neuroscience & therapeutics, 2023, Volume: 29, Issue:5

    Topics: Alzheimer Disease; Biological Products; Humans; Ligands; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate

2023
NMDA Receptor-Arc Signaling Is Required for Memory Updating and Is Disrupted in Alzheimer's Disease.
    Biological psychiatry, 2023, 11-01, Volume: 94, Issue:9

    Topics: Alzheimer Disease; Animals; Glycogen Synthase Kinase 3; Hippocampus; Humans; Mechanistic Target of Rapamycin Complex 2; Mice; Mice, Knockout; Mice, Transgenic; N-Methylaspartate; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, N-Methyl-D-Aspartate; Signal Transduction

2023
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.
    Neurobiology of disease, 2023, Volume: 184

    Topics: Alzheimer Disease; Amino Acids; Amyotrophic Lateral Sclerosis; Homeostasis; Humans; N-Methylaspartate; Parkinson Disease; Putamen; Receptors, N-Methyl-D-Aspartate; Serine

2023
Multivalent Tau/PSD-95 interactions arrest in vitro condensates and clusters mimicking the postsynaptic density.
    Nature communications, 2023, 10-27, Volume: 14, Issue:1

    Topics: Alzheimer Disease; Disks Large Homolog 4 Protein; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; N-Methylaspartate; Nerve Tissue Proteins; Post-Synaptic Density; Receptors, N-Methyl-D-Aspartate

2023
Can an FDA-Approved Alzheimer's Drug Be Repurposed for Alleviating Neuronal Symptoms of Zika Virus?
    mBio, 2017, 06-27, Volume: 8, Issue:3

    Topics: Alzheimer Disease; Cell Death; Humans; N-Methylaspartate; Zika Virus; Zika Virus Infection

2017
A Small Molecule Mimetic of the Humanin Peptide as a Candidate for Modulating NMDA-Induced Neurotoxicity.
    ACS chemical neuroscience, 2018, 03-21, Volume: 9, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Death; Hippocampus; Intracellular Signaling Peptides and Proteins; N-Methylaspartate; Neurons

2018
Selective reduction of APP-BACE1 activity improves memory via NMDA-NR2B receptor-mediated mechanisms in aged PDAPP mice.
    Neurobiology of aging, 2019, Volume: 75

    Topics: Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Male; Memory; Mice, Transgenic; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate

2019
NrCAM is a marker for substrate-selective activation of ADAM10 in Alzheimer's disease.
    EMBO molecular medicine, 2019, Volume: 11, Issue:4

    Topics: Acitretin; ADAM10 Protein; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cell Adhesion Molecules; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; N-Methylaspartate; Neuronal Outgrowth; Neurons; Proteolysis; Proteome; Rats; RNA Interference; RNA, Small Interfering; Substrate Specificity; Tetraspanins

2019
Simultaneous Live Imaging of Multiple Endogenous Proteins Reveals a Mechanism for Alzheimer's-Related Plasticity Impairment.
    Cell reports, 2019, 04-16, Volume: 27, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disks Large Homolog 4 Protein; Female; Glutamic Acid; Hippocampus; Ionomycin; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Membrane Proteins; N-Methylaspartate; Neuronal Plasticity; Protein Transport; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synapses

2019
Trans-cinnamaldehyde improves neuroinflammation-mediated NMDA receptor dysfunction and memory deficits through blocking NF-κB pathway in presenilin1/2 conditional double knockout mice.
    Brain, behavior, and immunity, 2019, Volume: 82

    Topics: Acrolein; Alzheimer Disease; Animals; Female; Hippocampus; I-kappa B Proteins; Long-Term Potentiation; Male; Memory Disorders; Mice; Mice, Knockout; Microglia; N-Methylaspartate; Neuroprotective Agents; NF-kappa B; Presenilin-1; Presenilin-2; Receptors, N-Methyl-D-Aspartate; Signal Transduction

2019
L-type Ca2+ currents at CA1 synapses, but not CA3 or dentate granule neuron synapses, are increased in 3xTgAD mice in an age-dependent manner.
    Neurobiology of aging, 2014, Volume: 35, Issue:1

    Topics: Aging; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Amyloid beta-Peptides; Animals; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Calcium Channels, L-Type; Cells, Cultured; Cognition Disorders; Dentate Gyrus; Mice; Mice, Inbred C57BL; Mice, Transgenic; N-Methylaspartate; Patch-Clamp Techniques; Phosphorylation; Potassium Channels, Voltage-Gated; Synapses; tau Proteins

2014
β-amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3.
    Neurobiology of aging, 2014, Volume: 35, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Glycogen Synthase Kinase 3; Indoles; Male; Maleimides; Mice; Mice, Transgenic; Molecular Targeted Therapy; N-Methylaspartate; Neuronal Plasticity; Neurons; rab5 GTP-Binding Proteins; Rats; Receptors, N-Methyl-D-Aspartate

2014
Increasing burden of Alzheimer's disease by aging.
    Journal of Korean medical science, 2014, Volume: 29, Issue:7

    Topics: Aging; Alzheimer Disease; Cost of Illness; Excitatory Amino Acid Agonists; Health Behavior; Humans; N-Methylaspartate; Risk Factors

2014
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease.
    Neurobiology of aging, 2015, Volume: 36, Issue:1

    Topics: Aging; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cholinesterase Inhibitors; Disease Models, Animal; Hippocampus; Long-Term Potentiation; Mice, Transgenic; Molecular Targeted Therapy; Mutation; N-Methylaspartate; Neostigmine; Plaque, Amyloid

2015
Aβ selectively impairs mGluR7 modulation of NMDA signaling in basal forebrain cholinergic neurons: implication in Alzheimer's disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014, Oct-08, Volume: 34, Issue:41

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Choline O-Acetyltransferase; N-Methylaspartate; Nerve Degeneration; Neurons; Parasympathetic Nervous System; Prosencephalon; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Signal Transduction

2014
A multipronged, nutritional-based strategy for managing Alzheimer's disease.
    Medical hypotheses, 2016, Volume: 91

    Topics: Aged; Albumins; Aluminum; Alzheimer Disease; Amyloid beta-Peptides; Animals; Atrophy; Blood-Brain Barrier; Brain; Carbohydrate Metabolism; Diabetes Mellitus; Dietary Supplements; Gray Matter; Homocysteine; Humans; Learning; Magnesium; Magnesium Deficiency; Memory; Middle Aged; Models, Theoretical; N-Methylaspartate; Nutritional Sciences; Plasma Exchange; Rats; Silicic Acid; Vitamin B Complex

2016
Decreased levels of NMDA but not AMPA receptors in the lipid-raft fraction of 3xTg-AD model of Alzheimer's disease: Relation to Arc/Arg3.1 protein expression.
    Neurochemistry international, 2016, Volume: 100

    Topics: Alzheimer Disease; Animals; Cytoskeletal Proteins; Disease Models, Animal; Hippocampus; Male; Membrane Microdomains; Mice; Mice, Transgenic; N-Methylaspartate; Nerve Tissue Proteins; Neuronal Plasticity; Neurons; Post-Synaptic Density; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Synapses

2016
New azepino[4,3-b]indole derivatives as nanomolar selective inhibitors of human butyrylcholinesterase showing protective effects against NMDA-induced neurotoxicity.
    European journal of medicinal chemistry, 2017, Jan-05, Volume: 125

    Topics: Alzheimer Disease; Azepines; Butyrylcholinesterase; Cell Line, Tumor; Cholinesterase Inhibitors; Humans; Indoles; N-Methylaspartate; Neurons; Neuroprotective Agents

2017
TFP5, a Peptide Inhibitor of Aberrant and Hyperactive Cdk5/p25, Attenuates Pathological Phenotypes and Restores Synaptic Function in CK-p25Tg Mice.
    Journal of Alzheimer's disease : JAD, 2017, Volume: 56, Issue:1

    Topics: Alzheimer Disease; Animals; Antipsychotic Agents; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Doxycycline; Excitatory Amino Acid Agonists; Exploratory Behavior; Female; Hippocampus; Hyperkinesis; Long-Term Potentiation; Male; Maze Learning; Mice; Mice, Transgenic; Motor Activity; N-Methylaspartate; Peptides; Phosphotransferases; tau Proteins

2017
Aluminum modulates effects of beta amyloid(1-42) on neuronal calcium homeostasis and mitochondria functioning and is altered in a triple transgenic mouse model of Alzheimer's disease.
    Rejuvenation research, 2008, Volume: 11, Issue:5

    Topics: Aluminum; Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium Signaling; Disease Models, Animal; Homeostasis; Humans; In Vitro Techniques; Male; Membrane Fluidity; Mice; Mice, Transgenic; Mitochondria; Multiprotein Complexes; N-Methylaspartate; Neurons; Oxygen Consumption; Peptide Fragments; Rats; Rats, Wistar

2008
Evaluation of the impact of memantine treatment initiation on psychotropics use: a study from the French national health care database.
    Neuroepidemiology, 2008, Volume: 31, Issue:3

    Topics: Aged; Alzheimer Disease; Anti-Anxiety Agents; Antipsychotic Agents; Databases, Factual; Dopamine Agents; Female; France; Humans; Hypnotics and Sedatives; Male; Memantine; N-Methylaspartate; Psychotropic Drugs; Treatment Outcome

2008
Memantine inhibits calpain-mediated truncation of GSK-3 induced by NMDA: implications in Alzheimer's disease.
    Journal of Alzheimer's disease : JAD, 2009, Volume: 18, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Calpain; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Female; Glycogen Synthase Kinase 3; Humans; Inhibitory Concentration 50; Male; Memantine; Middle Aged; N-Methylaspartate; Neurons; Phosphorylation; Receptors, N-Methyl-D-Aspartate; Signal Transduction

2009
S 24795 limits beta-amyloid-alpha7 nicotinic receptor interaction and reduces Alzheimer's disease-like pathologies.
    Biological psychiatry, 2010, Mar-15, Volume: 67, Issue:6

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium; Cholinergic Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Frontal Lobe; Hippocampus; Immunoprecipitation; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; N-Methylaspartate; Organ Culture Techniques; Peptide Fragments; Phosphorylation; Pyridinium Compounds; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Synaptosomes

2010
[Alzheimer dementia. Memantine: value for patient and caregivers].
    MMW Fortschritte der Medizin, 2009, Nov-05, Volume: 151, Issue:45

    Topics: Activities of Daily Living; Aged; Alzheimer Disease; Caregivers; Cognition; Cost of Illness; Dopamine Agents; Humans; Memantine; N-Methylaspartate

2009
NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Sep-08, Volume: 30, Issue:36

    Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cadmium Chloride; Caffeine; Central Nervous System Stimulants; Disease Models, Animal; Drug Interactions; Electric Stimulation; Endoplasmic Reticulum; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Gene Expression Regulation; Heparin; Humans; In Vitro Techniques; Membrane Potentials; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Mutation; N-Methylaspartate; Patch-Clamp Techniques; Prefrontal Cortex; Presenilin-1; Pyramidal Cells; Ryanodine Receptor Calcium Release Channel; tau Proteins; Transglutaminases

2010
The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease.
    Journal of Alzheimer's disease : JAD, 2010, Volume: 22, Issue:2

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Antipsychotic Agents; Calcium; Cells, Cultured; Cerebral Cortex; Diazoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Excitatory Amino Acid Agonists; Gene Expression Regulation; Humans; KATP Channels; Membrane Potential, Mitochondrial; Membrane Potentials; Memory Disorders; Mice; Mice, Transgenic; Mutation; N-Methylaspartate; Oxygen; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; Presenilin-1; Rats; RNA, Messenger; tau Proteins; Tauopathies

2010
Molecular changes in brain aging and Alzheimer's disease are mirrored in experimentally silenced cortical neuron networks.
    Neurobiology of aging, 2012, Volume: 33, Issue:1

    Topics: Aging; Alzheimer Disease; Animals; Calcium Signaling; Cell Survival; Cells, Cultured; Cerebral Cortex; Electroshock; Energy Metabolism; Environment; Gene Expression; Humans; Interneurons; Lipid Metabolism; Mice; Mice, Inbred C57BL; N-Methylaspartate; Nerve Net; Neuronal Plasticity; Receptor, trkB; Synaptic Transmission

2012
[About the NMDA-system again].
    Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology, 2011, Volume: 13, Issue:1

    Topics: Alcoholism; Alzheimer Disease; Animals; Antipsychotic Agents; Excitatory Amino Acid Agonists; Glutamic Acid; Humans; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Synapses

2011
S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, Aug-23, Volume: 108, Issue:34

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Brain; Cyclin-Dependent Kinase 5; Cysteine; Dendritic Spines; Dynamins; Enzyme Activation; HEK293 Cells; Humans; Mutation; N-Methylaspartate; Nitric Oxide; Nitrosation; Rats; Synapses

2011
Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures.
    Cell calcium, 2012, Volume: 51, Issue:2

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium; Cell Death; Cells, Cultured; Cerebral Cortex; Homeostasis; N-Methylaspartate; Neurons; Peptide Fragments; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission

2012
[New anti-AD drugs--their possibilities and issues].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 2012, Volume: 114, Issue:3

    Topics: Alzheimer Disease; Cholinesterase Inhibitors; Galantamine; Humans; Memantine; N-Methylaspartate; Phenylcarbamates; Rivastigmine

2012
Interleukin-6, beta-amyloid peptide and NMDA interactions in rat cortical neurons.
    Journal of neuroimmunology, 2003, Volume: 139, Issue:1-2

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcium Signaling; Cell Death; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Drug Interactions; Encephalitis; Excitatory Amino Acid Agonists; Fetus; Glutamic Acid; Interleukin-6; N-Methylaspartate; Nerve Degeneration; Neurons; Neurotoxins; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate

2003
[Early treatment with anti-dementia drugs when possible. These signs reveal Alzheimer disease].
    MMW Fortschritte der Medizin, 2003, Jun-05, Volume: 145, Issue:23

    Topics: Alzheimer Disease; Cholinesterase Inhibitors; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Humans; Memantine; N-Methylaspartate

2003
Memantine in moderate-to-severe Alzheimer's disease.
    The New England journal of medicine, 2003, Aug-07, Volume: 349, Issue:6

    Topics: Alzheimer Disease; Excitatory Amino Acid Antagonists; Homocysteine; Humans; Hyperhomocysteinemia; Memantine; N-Methylaspartate

2003
Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2004, Volume: 18, Issue:3

    Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cells, Cultured; Cellular Senescence; Chick Embryo; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Eye Proteins; Glutamic Acid; Kainic Acid; N-Methylaspartate; Neurons; Neuroprotective Agents; Picrotoxin; Receptors, AMPA; Receptors, GABA; Receptors, GABA-A; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Retina; Taurine

2004
Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease.
    Journal of neurology, neurosurgery, and psychiatry, 2004, Volume: 75, Issue:4

    Topics: Afferent Pathways; Aged; Alzheimer Disease; Carbamates; Cerebral Cortex; Cholinergic Fibers; Cholinesterase Inhibitors; Evoked Potentials, Motor; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Motor Cortex; Muscle, Skeletal; N-Methylaspartate; Nerve Net; Neural Inhibition; Phenylcarbamates; Reaction Time; Rivastigmine; Sensory Thresholds; Signal Processing, Computer-Assisted; Transcranial Magnetic Stimulation

2004
Amyloid-beta induced cell death is independent of free radicals.
    Journal of Alzheimer's disease : JAD, 2004, Volume: 6, Issue:6

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Animals, Newborn; Calcium; Carnosine; Cell Death; Cell Survival; Cerebellum; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescent Dyes; Free Radicals; Indicators and Reagents; Intracellular Space; Kainic Acid; N-Methylaspartate; Neurons; Propidium; Rats; Reactive Oxygen Species; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Xanthenes

2004
[Treatment of Alzheimer's disease utilising the best available evidence-based medicine -- utopia?].
    Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)), 2005, Volume: 67, Issue:1

    Topics: Adult; Alzheimer Disease; Calcium Channel Blockers; Cholinesterase Inhibitors; Drug Costs; Evidence-Based Medicine; Family Practice; Germany; Ginkgo biloba; Humans; Interviews as Topic; Medicine; Middle Aged; N-Methylaspartate; Nootropic Agents; Phytotherapy; Specialization

2005
Memantine for treatment of moderate to severe Alzheimer's disease.
    Issues in emerging health technologies, 2005, Issue:64

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Canada; Cholinesterase Inhibitors; Dementia; Diffusion of Innovation; Dopamine Agents; Drug Approval; Drug Therapy, Combination; Humans; Indans; Memantine; N-Methylaspartate; Nootropic Agents; Randomized Controlled Trials as Topic; Risk Factors

2005
Vascular endothelial growth factor counteracts NMDA-induced cell death of adult cholinergic neurons in rat basal nucleus of Meynert.
    Brain research bulletin, 2005, Mar-15, Volume: 65, Issue:2

    Topics: Age Factors; Alzheimer Disease; Animals; Axotomy; Basal Nucleus of Meynert; Blood Vessels; Cell Death; Choline O-Acetyltransferase; Cholinergic Fibers; Disease Models, Animal; Excitatory Amino Acid Agonists; Immunohistochemistry; Laminin; Male; N-Methylaspartate; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A

2005
On the paradox of ion channel blockade and its benefits in the treatment of Alzheimer disease.
    Medical hypotheses, 2005, Volume: 65, Issue:2

    Topics: Alzheimer Disease; Brain; Calcium; Calcium Channel Blockers; Clinical Trials as Topic; Humans; Ion Channels; Models, Theoretical; N-Methylaspartate

2005
Regulation of NMDA receptor trafficking by amyloid-beta.
    Nature neuroscience, 2005, Volume: 8, Issue:8

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Calcineurin; Cell Membrane; Cerebral Cortex; CREB-Binding Protein; Disease Models, Animal; Electric Conductivity; Endocytosis; Enzyme Activation; Mice; N-Methylaspartate; Neurons; Nuclear Proteins; Peptide Fragments; Protein Transport; Protein Tyrosine Phosphatases; Protein Tyrosine Phosphatases, Non-Receptor; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Signal Transduction; Synapses; Trans-Activators

2005
Basic brain research shows its age.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2005, Volume: 13, Issue:12

    Topics: Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Brain; Dentate Gyrus; Gene Expression; Hippocampus; Hormone Replacement Therapy; Humans; Membrane Proteins; N-Methylaspartate; Oligonucleotide Array Sequence Analysis; Presenilin-1

2005
Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    The European journal of neuroscience, 2006, Volume: 23, Issue:8

    Topics: Action Potentials; Age Factors; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Animals, Newborn; Disease Models, Animal; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Gene Expression; Immunohistochemistry; Male; Mice; Mice, Transgenic; N-Methylaspartate; Neocortex; Patch-Clamp Techniques; Pyramidal Cells; Receptors, AMPA; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Synapses; Time Factors

2006
S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
    Nature, 2006, May-25, Volume: 441, Issue:7092

    Topics: Alzheimer Disease; Animals; Binding Sites; Cell Line; Cysteine; Endoplasmic Reticulum; Humans; Molecular Chaperones; N-Methylaspartate; Neurodegenerative Diseases; Nitric Oxide; Parkinson Disease; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Disulfide-Isomerases; Protein Folding; Receptors, G-Protein-Coupled; Sulfhydryl Compounds; Ubiquitin

2006
Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Neuroscience, 2007, Jun-15, Volume: 147, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognition Disorders; Disease Models, Animal; Entorhinal Cortex; Exploratory Behavior; Gliosis; Male; Maze Learning; Microinjections; N-Methylaspartate; Neurotoxins; Peptide Fragments; Plaque, Amyloid; Rats; Rats, Wistar; Recognition, Psychology; Statistics, Nonparametric

2007
Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons.
    Journal of neurochemistry, 2008, Volume: 106, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Arachidonic Acid; Cells, Cultured; Cerebral Cortex; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Extracellular Signal-Regulated MAP Kinases; N-Methylaspartate; NADPH Oxidases; Neurons; Oxidative Stress; Peptide Fragments; Phospholipases A2, Cytosolic; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Signal Transduction

2008
Basal forebrain cholinergic neurons are selectively vulnerable to AMPA/kainate receptor-mediated neurotoxicity.
    Neuroscience, 1994, Volume: 60, Issue:3

    Topics: Acetylcholine; Acetylcholinesterase; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Animals; Cells, Cultured; Choline O-Acetyltransferase; Kainic Acid; Mice; N-Methylaspartate; Nerve Tissue Proteins; Neurons; Prosencephalon; Receptors, AMPA; Receptors, Kainic Acid

1994
Role of glutamate and glutamate receptors in memory function and Alzheimer's disease.
    Annals of the New York Academy of Sciences, 1995, May-10, Volume: 757

    Topics: Adult; Aged; Alzheimer Disease; Animals; Cognition; Cycloserine; Discrimination Learning; Entorhinal Cortex; Female; Glutamic Acid; Humans; Male; Memory; N-Methylaspartate; Rats; Receptors, Glutamate; Temporal Lobe

1995
Neuroprotective activity of acetyl-L-carnitine: studies in vitro.
    Journal of neuroscience research, 1994, Volume: 37, Issue:1

    Topics: Acetylcarnitine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood Physiological Phenomena; Cattle; Cell Death; Cells, Cultured; Cerebral Cortex; Culture Media; Energy Metabolism; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Hippocampus; Humans; Kainic Acid; N-Methylaspartate; Neurons; Peptide Fragments; Rats

1994
Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1994, Volume: 14, Issue:11 Pt 1

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amino Acids; Autoradiography; Binding Sites; Carrier Proteins; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Glutamic Acid; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; N-Methylaspartate; Nerve Tissue Proteins; Parkinson Disease; Receptors, Amino Acid; Receptors, AMPA; Receptors, Glutamate

1994
Presence of the N-methyl-D-aspartate-associated glycine receptor agonist, D-serine, in human temporal cortex: comparison of normal, Parkinson, and Alzheimer tissues.
    Journal of neurochemistry, 1993, Volume: 61, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Animals; Gas Chromatography-Mass Spectrometry; Humans; Middle Aged; N-Methylaspartate; Parkinson Disease; Rats; Receptors, Glycine; Receptors, Neurotransmitter; Reference Values; Serine; Temporal Lobe

1993
Modifications of neuronal phosphorylated tau immunoreactivity induced by NMDA toxicity.
    Molecular and chemical neuropathology, 1996, Volume: 27, Issue:3

    Topics: Alzheimer Disease; Animals; Brain; Cell Survival; Cells, Cultured; Cerebral Cortex; Fetus; Humans; Kinetics; N-Methylaspartate; Neurons; Neurotoxins; Phosphoproteins; Phosphorylation; Rats; tau Proteins; Time Factors

1996
Effects of entorhinal cortex lesions on memory in different tasks.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1997, Volume: 30, Issue:6

    Topics: Alzheimer Disease; Animals; Avoidance Learning; Behavior, Animal; Entorhinal Cortex; Excitatory Amino Acid Agents; Male; Maze Learning; Memory Disorders; N-Methylaspartate; Rats; Rats, Wistar; Stereotaxic Techniques

1997
Behavioral disturbances without amyloid deposits in mice overexpressing human amyloid precursor protein with Flemish (A692G) or Dutch (E693Q) mutation.
    Neurobiology of disease, 2000, Volume: 7, Issue:1

    Topics: Aggression; Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Animals; Brain; Cell Nucleus; Cerebral Amyloid Angiopathy; Humans; Kainic Acid; Lethal Dose 50; Mice; Mice, Inbred Strains; Mice, Transgenic; N-Methylaspartate; Point Mutation

2000
No effect of apolipoprotein E on neuronal cell death due to excitotoxic and apoptotic agents in vitro and neonatal hypoxic ischaemia in vivo.
    The European journal of neuroscience, 2000, Volume: 12, Issue:7

    Topics: Alzheimer Disease; Animals; Animals, Newborn; Antibodies; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Apoptosis; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Gene Expression; Humans; Hypoxia-Ischemia, Brain; In Vitro Techniques; Mice; Mice, Inbred CBA; Mice, Knockout; N-Methylaspartate; Neurons; Neurotoxins; Staurosporine

2000
Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically.
    Proceedings of the National Academy of Sciences of the United States of America, 2000, Nov-07, Volume: 97, Issue:23

    Topics: Alzheimer Disease; Animals; Brain; Cells, Cultured; Disease Models, Animal; Excitatory Amino Acid Agonists; Gene Expression; Humans; Infarction, Middle Cerebral Artery; Kainic Acid; Membrane Proteins; Mice; Mice, Knockout; Mice, Transgenic; N-Methylaspartate; Nerve Degeneration; Neurons; Presenilin-1

2000
Effect of amyloid beta peptide on poly(ADP-ribose) polymerase activity in adult and aged rat hippocampus.
    Acta biochimica Polonica, 2000, Volume: 47, Issue:3

    Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cerebral Cortex; DNA Damage; Free Radicals; Hippocampus; Humans; N-Methylaspartate; Nerve Degeneration; Nitric Oxide; Peptide Fragments; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar

2000
Neuronal injury-induced expression and release of apolipoprotein E in mixed neuron/glia co-cultures: nuclear factor kappaB inhibitors reduce basal and lesion-induced secretion of apolipoprotein E.
    Neuroscience, 2001, Volume: 104, Issue:1

    Topics: Alzheimer Disease; Animals; Antibodies; Apolipoproteins E; Cell Death; Cell Division; Cells, Cultured; Coculture Techniques; Dose-Response Relationship, Drug; Embryo, Mammalian; Excitatory Amino Acid Agonists; Glial Fibrillary Acidic Protein; Models, Animal; N-Methylaspartate; Nerve Degeneration; Neuroglia; Neurons; NF-kappa B; Rats; Rats, Sprague-Dawley; RNA, Messenger; Synaptophysin; Time Factors; Up-Regulation

2001
Huperzine A, a nootropic alkaloid, inhibits N-methyl-D-aspartate-induced current in rat dissociated hippocampal neurons.
    Neuroscience, 2001, Volume: 105, Issue:3

    Topics: Alkaloids; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Animals; Cells, Cultured; Dithiothreitol; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Glycine; Hippocampus; Hydrogen-Ion Concentration; Kainic Acid; Membrane Potentials; N-Methylaspartate; Neuroprotective Agents; Nootropic Agents; Patch-Clamp Techniques; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sesquiterpenes; Spermine; Zinc

2001
Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus.
    Neurobiology of learning and memory, 2002, Volume: 77, Issue:3

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Calcineurin; Cyclosporine; Dentate Gyrus; Disease Models, Animal; Hippocampus; Immunosuppressive Agents; Long-Term Potentiation; Male; N-Methylaspartate; Phospholipids; Rats; Rats, Sprague-Dawley; Tacrolimus

2002
Distinct subsets of nucleus basalis neurons exhibit similar sensitivity to excitotoxicity.
    Neuroreport, 2002, May-07, Volume: 13, Issue:6

    Topics: Acetylcholine; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Basal Nucleus of Meynert; Biomarkers; Carbocyanines; Cell Count; Choline O-Acetyltransferase; Cholinergic Fibers; Down-Regulation; Fluorescent Dyes; Immunoglobulin G; Immunohistochemistry; Male; N-Methylaspartate; Neurons; Neurotoxins; Nuclear Proteins; Rats; Rats, Wistar; Receptor, Nerve Growth Factor

2002
Increased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis of Meynert.
    Brain research. Molecular brain research, 1991, Volume: 10, Issue:2

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Autoradiography; Cerebral Cortex; Choline O-Acetyltransferase; Electrophoresis, Gel, Two-Dimensional; Humans; Male; Methionine; N-Methylaspartate; Polyribosomes; Protein Biosynthesis; Protein Precursors; Rats; Rats, Inbred Strains; Substantia Innominata; Sulfur Radioisotopes

1991
L-phosphoserine, a metabolite elevated in Alzheimer's disease, interacts with specific L-glutamate receptor subtypes.
    Journal of neurochemistry, 1991, Volume: 56, Issue:6

    Topics: 2-Amino-5-phosphonovalerate; Alzheimer Disease; Animals; Dizocilpine Maleate; Dose-Response Relationship, Drug; Glutamates; Glycine; Kainic Acid; N-Methylaspartate; Phosphoserine; Rats; Receptors, Glutamate; Receptors, Neurotransmitter

1991
Trophic factor effects on septal cholinergic neurons.
    Annals of the New York Academy of Sciences, 1991, Volume: 640

    Topics: Alzheimer Disease; Animals; Brain-Derived Neurotrophic Factor; Cells, Cultured; Cholinergic Fibers; Female; Hippocampus; Male; N-Methylaspartate; Nerve Growth Factors; Nerve Tissue Proteins; Neurons; Rats; Septal Nuclei

1991
[3H]N-[1-(2-thienyl)cyclohexyl]-3,4-piperidine ([3H]TCP) binding in human frontal cortex: decreases in Alzheimer-type dementia.
    Journal of neurochemistry, 1990, Volume: 54, Issue:2

    Topics: Alzheimer Disease; Aspartic Acid; Binding Sites; Frontal Lobe; Glutamates; Glutamic Acid; Humans; Membranes; N-Methylaspartate; Phencyclidine; Reference Values

1990
Selective reduction of quisqualate (AMPA) receptors in Alzheimer cerebellum.
    Annals of neurology, 1990, Volume: 28, Issue:6

    Topics: Aged; Aged, 80 and over; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Alzheimer Disease; Autoradiography; Cerebellum; Female; Glutamates; Glutamic Acid; Humans; Ibotenic Acid; Kainic Acid; Kinetics; Male; N-Methylaspartate; Radioligand Assay; Receptors, AMPA; Receptors, Neurotransmitter

1990
NMDA depolarizations and long-term potentiation are reduced in the aged rat neocortex.
    Brain research, 1990, Oct-15, Volume: 530, Issue:1

    Topics: Aging; Alzheimer Disease; Animals; Cerebral Cortex; Disease Models, Animal; Electric Stimulation; In Vitro Techniques; Membrane Potentials; N-Methylaspartate; Neurons; Rats; Rats, Inbred F344; Time Factors

1990
Beta-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage.
    Brain research, 1990, Nov-19, Volume: 533, Issue:2

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Glutamates; Kainic Acid; L-Lactate Dehydrogenase; Mice; N-Methylaspartate; Nerve Tissue Proteins; Neurons; Neurotoxins

1990
Plasticity in hippocampal excitatory amino acid receptors in Alzheimer's disease.
    Neuroscience research, 1986, Volume: 3, Issue:6

    Topics: Aged; Alzheimer Disease; Aspartic Acid; Autoradiography; Female; Glutamates; Glutamic Acid; Hippocampus; Humans; Kainic Acid; Male; Middle Aged; N-Methylaspartate; Neuronal Plasticity; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Synaptic Transmission

1986
Dementia of the Alzheimer's type: changes in hippocampal L-[3H]glutamate binding.
    Journal of neurochemistry, 1987, Volume: 48, Issue:2

    Topics: Alzheimer Disease; Aspartic Acid; Autoradiography; Flunitrazepam; Glutamates; Glutamic Acid; Hippocampus; Histocytochemistry; Humans; Muscimol; N-Methylaspartate; Receptors, GABA-A; Receptors, Muscarinic; Tissue Distribution

1987
Anatomical organization of excitatory amino acid receptors and their properties.
    Advances in experimental medicine and biology, 1986, Volume: 203

    Topics: Alzheimer Disease; Animals; Aspartic Acid; Autoradiography; Brain; Brain Mapping; Calcium; Glutamates; Humans; N-Methylaspartate; Rats; Receptors, AMPA; Receptors, Drug; Receptors, Glutamate; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Structure-Activity Relationship

1986